ONE Cardio
Natural health product licensed in Canada
- Other names
- ONE Longevity
- Licence holder
- Integral Health Science Inc.
- NPN or DIN-HM
- 80143754
- Status
- Active licence
- Licence date
- 1 September 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| trans-Resvératrol Source : Resvératrol | 66.67 mg | Not calculated |
| trans-Resvératrol Source : Vitis vinifera - Fruit | 66.67 mg | Not calculated |
| Allium sativum Source : Allium sativum - Bulbe Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 166.67 mg | 41.67 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 10 mg | Not calculated |
| Magnésium Source : Citrate de magnésium | 33.33 mg | 99,990 µg |
| Chrome Source : Picolinate de chrome (III) | 166.66 Microgrammes | Not calculated |
| 5,6-Dihydro-9,10-diméthoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium Source : Berberine | 166.67 mg | Not calculated |
| Policosanol Source : Policosanol | 3.33 mg | Not calculated |
| 3-(Aminocarbonyl)-1-(5-O-phosphonato-bêta -D-ribofuranosyl)pyridinium | 83.33 mg | Not calculated |
| Beta vulgaris Source : Beta vulgaris - Racine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 300 mg | 15 mg | Not calculated |
| Levure de riz rouge Source : Oryza sativa - Graine | 333.33 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Stéarate de magnésium, Dioxyde de silicium, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain/support heart muscle function. Provides support for healthy glucose metabolism. Used in Herbal Medicine to help reduce elevated blood lipid levels (hyperlipidemia) in adults. Helps to maintain and/or support cardiovascular health. Source of (an) antioxidant(s)/Provides (an) antioxidant(s).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80143754
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.